Abstract:Background Microglia, the major cell type that mediates active immune defence in the central nervous system (CNS), constantly survey the brain parenchyma through highly motile processes. Mounting evidence has implicated both beneficial and toxic roles of microglia when over-activated upon neuronal injury. Understanding the function of microglia in the brain may uncover the regulatory mechanisms for neuroinflammation and facilitate the development of a novel therapeutic strategy for Alzheimer's disease (AD). The ε4 allele of apolipoprotein E (APOE) is a major genetic risk factor for the late onset AD. ApoE, as the major cholesterol carrier in the brain, has been implicated in AD pathogenesis. However, how APOE and APOE isoforms directly regulate microglial functions remains largely unknown. Methods Using primary culture of microglia from Apoe knockout (KO) mice, APOE3 and APOE4 targeted replacement (TR) mouse, we investigated the characteristics of microglial secreted apoE particles and the biological effects of apoE isoforms on microglial inflammatory response, migratory ability, cell viability and proliferation. Meanwhile, microglia-neuron co-culture system was utilized to study the effects of apoE isoforms on neurite outgrowth.Results Herein, we found that microglia secret abundant lipidated apoE. Interestingly, apoE4 particles from primary microglia exhibited a higher lipidation status compared to apoE3 particles. Furthermore, apoE4 microglia exhibited a reduced migratory ability as well as enhanced inflammatory responses and neurotoxicity, indicating microglial apoE4 is involved in unfavourable functions. Conclusions Our findings revealed the critical roles for apoE and apoE isoforms in regulating microglial functions. Our results also indicate that targeting apoE-mediated microglial inflammatory responses may serve as a potential therapeutic strategy for AD.

Role of APOE in glaucoma

Apolipoprotein E4 impairs the response of neurodegenerative retinal microglia and prevents neuronal loss in glaucoma

Apolipoprotein ε in Brain and Retinal Neurodegenerative Diseases

Apolipoprotein E4 expressed by microglia impairs microglial functions and enhances neurotoxicity

Multifaceted roles of APOE in Alzheimer disease

Protection of retinal ganglion cells in glaucoma: Current status and future

Tackling retinal ganglion cell apoptosis in glaucoma: role of adenosine receptors

Roles of Optineurin and Extracellular Vesicles in Glaucomatous Retinal Cell Loss

The Role of APOE4 in Disrupting the Homeostatic Functions of Astrocytes and Microglia in Aging and Alzheimer’s Disease

Lack Of Association Of Apolipoprotein E (Apo E) Epsilon 2/Epsilon 3/Epsilon 4 Polymorphisms With Primary Open-Angle Glaucoma: A Meta-Analysis From 1916 Cases And 1756 Controls

APOE4 impairs the microglial response in Alzheimer's disease by inducing TGF-mediated checkpoints

APOEε4 and risk of Alzheimer's disease – time to move forward

Exploring the role of apolipoprotein E gene promoter polymorphisms in susceptibility to normal-tension glaucoma in a Korean population

Human Glia‐specific Functional Dysregulations Affected by APOE Ε4 Risk of Alzheimer's Disease

Signaling Pathways of Apoe and Its Role of Gene Expression in Glomerulus Diseases

Cell type-specific roles of APOE4 in Alzheimer disease

APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFβ-mediated checkpoints

Role of Apolipoprotein E in Alzheimer's Disease Pathogenesis, Prognosis and Treatment

A multi‐hit hypothesis for an APOE4‐dependent pathophysiological state

APOE2 promotes the development and progression of subretinal neovascularization in age-related macular degeneration via MAPKs signaling pathway

Neuronal ApoE4 in Alzheimer's disease and potential therapeutic targets